Virus-Like Particle Production

Using QMCF Technology production of virus-like particles for vaccine development, investigation of receptor functions or for production of membrane proteins is highly efficient.

Production of proteins

Expression of viral envelope or capside proteins results self-assembly of virus-like particles (VLP-s). VLP-s could be produced in different cell systems, including mammalian, insect, yeast and plant cells. One good possibility to produce membrane proteins in functional and correct conformational manner is expression of these proteins in composition of virus like particles (VLP-s). VLP-s could be used for different approaches e.g. vaccine development, investigation of receptor functions and also for purification of different membrane proteins.

 

Custom VLP Production Services include

Cloning

Expression analysis

Expression optimization (optional)

Scaled-up expression and purification

Codon optimization and synthesis of cDNA (optional)

Cloning of cDNA into QMCF VLP expression plasmids

Expression in suspension QMCF/293 cells in small scale

Primary detection of protein and VLP expression

Generation of expression cell banks

Selection of expression vectors, optimization of growth media and conditions, cell lines

Detection of protein and VLP expression

Generation of expression cell banks

Expanding the culture volume

Detection of protein and VLP expression

Purification of the product by ultracentrifugation or precipitation and gel-filtration

 

3-4 weeks gene synthesis;

1 week cloning

2-3 days

Min 4-5 weeks

Min 3-4 weeks

Price starts from EUR 2000 for cloning and expression analysis

Inquire

Price starts from EUR 2500


Read more about protein production and QMCF Technology